Consolidated Balance Sheets - USD ($) shares in Thousands, $ in Millions	Sep. 30, 2022	Sep. 30, 2021
Current Assets
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 1,804	$ 2,354
Receivables, less allowances of $108 in 2022 and $116 in 2021	3,008	2,971
Inventories	2,191	2,050
Other current assets	1,503	1,057
Total current assets	8,506	8,432
Property, plant and equipment, net	3,361	3,738
Other assets
Goodwill	14,662	7,723
Other intangible assets	6,724	2,877
Other	2,419	1,945
Total other assets	23,805	12,545
Total assets	35,672	24,715
LIABILITIES AND EQUITY
Short-term borrowings and current maturities of long-term debt	2,115	872
Accounts payable	2,028	2,108
Accrued expenses	3,634	3,266
Total current liabilities	7,777	6,246
Long-term debt	8,259	5,793
Other liabilities	3,320	2,753
Equity
Common stock, $0.50 par value per share; authorized, 1,200.0 shares; issued, 953.4 shares; outstanding, 591.4 shares in 2022 and 595.8 shares in 2021	477	477
Additional paid-in-capital	57	522
Retained earnings	28,053	26,047
Accumulated other comprehensive income (loss)	(1,485)	(872)
Common stockholders' equity before treasury stock	27,102	26,174
Less: Cost of common stock in treasury, 362.0 shares in 2022 and 357.6 shares in 2021	16,738	16,291
Common stockholders’ equity	10,364	9,883
Noncontrolling interests in subsidiaries	5,952	40
Total equity	16,316	9,923
Total liabilities and equity	$ 35,672	$ 24,715
Common stock, par value per share	$ 0.50	$ 0.50
Common stock, shares authorized	1,200,000	1,200,000
Common stock, shares issued	953,400	953,400